BBA

Baker Bros. Advisors Portfolio holdings

AUM $17.1B
1-Year Est. Return 139.98%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+139.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.1B
AUM Growth
+$3.24B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1 +$135M
2 +$92.2M
3 +$81.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$60.9M
5
ALKS icon
Alkermes
ALKS
+$57.5M

Top Sells

1 +$54.1M
2 +$47.4M
3 +$39M
4
RNAM
Avidity Biosciences
RNAM
+$27.2M
5
PCVX icon
Vaxcyte
PCVX
+$23.1M

Sector Composition

1 Healthcare 99.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERS icon
51
Cerus
CERS
$386M
$20.6M 0.12%
10,008,345
NGNE icon
52
Neurogene
NGNE
$317M
$20.4M 0.12%
991,691
TECX
53
Tectonic Therapeutic
TECX
$577M
$18.8M 0.11%
903,400
+803,400
CTMX icon
54
CytomX Therapeutics
CTMX
$981M
$18.1M 0.11%
4,250,826
CLDX icon
55
Celldex Therapeutics
CLDX
$2.62B
$18.1M 0.11%
665,370
XNCR icon
56
Xencor
XNCR
$917M
$16.9M 0.1%
1,102,106
CNTA
57
Centessa Pharmaceuticals
CNTA
$6.11B
$16.8M 0.1%
+670,751
XENE icon
58
Xenon Pharmaceuticals
XENE
$5.57B
$16.6M 0.1%
370,208
SION
59
Sionna Therapeutics
SION
$1.95B
$16.5M 0.1%
400,000
CTNM
60
Contineum Therapeutics
CTNM
$481M
$16.2M 0.1%
1,420,838
+1,343,168
SERA icon
61
Sera Prognostics
SERA
$77.1M
$16.2M 0.1%
5,498,170
DYN icon
62
Dyne Therapeutics
DYN
$3.27B
$15.9M 0.09%
+813,449
ALMS
63
Alumis Inc
ALMS
$2.93B
$15.3M 0.09%
1,562,500
NUVL icon
64
Nuvalent
NUVL
$8.26B
$14.5M 0.08%
143,937
PHVS icon
65
Pharvaris
PHVS
$1.74B
$10.4M 0.06%
375,000
RLAY icon
66
Relay Therapeutics
RLAY
$2.64B
$9.81M 0.06%
1,160,117
ABSI icon
67
Absci
ABSI
$482M
$7.45M 0.04%
+2,134,803
RCUS icon
68
Arcus Biosciences
RCUS
$2.88B
$6.43M 0.04%
+270,000
MPLT
69
MapLight Therapeutics
MPLT
$1.13B
$6.41M 0.04%
+364,705
VTVT icon
70
vTv Therapeutics
VTVT
$144M
$5.93M 0.03%
148,314
WVE icon
71
Wave Life Sciences
WVE
$1.35B
$5.85M 0.03%
344,063
SGMT icon
72
Sagimet Biosciences
SGMT
$173M
$5.64M 0.03%
952,996
TARA icon
73
Protara Therapeutics
TARA
$268M
$5.18M 0.03%
971,614
+434,782
LBRX
74
LB Pharmaceuticals
LBRX
$698M
$4.45M 0.03%
200,000
ELVN icon
75
Enliven Therapeutics
ELVN
$2.71B
$4.18M 0.02%
271,406
+156,573